Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Sandra who wrote (27192)	12/13/1998 1:21:00 AM
From: Jane4IceCream	Read Replies (2) \| Respond to of 119973

Hey Sandra! What are you doing up so late! Looks like to me the 3 most talked about stocks this weekend on this thread are SEEK, ASTM, and FILE. And I am holding all 3!! Looks like Monday morning is going to be sweet. Wish it were here now. Hopefully, Clinton can keep his d*ck in his pants the rest of the weekend. Jane

To: Sandra who wrote (27192)	12/13/1998 1:23:00 AM
From: JEB	Read Replies (2) \| Respond to of 119973

The researchers who helped pioneer this technology and paved the road for ASTM technology: UI - 97082555 AU - Ohnuma K; Toyoda Y; Nishihira H; Iguchi A; Honda K; Nagao T; Kigasawa H TI - Successful engraftment of sibling cord-blood stem cell transplantation in a child with acute promyelocytic leukemia. SO - Int J Hematol 1996;64(3-4):271-8 AD - Department of Oncology, Kanagawa Children's Medical Center, Yokohama, Japan. Cord blood stem cell transplantation (CBSCT) was performed on a patient with acute promyelocytic leukemia. The patient was a boy 3 years and 8 months old, who had shown complete remission following treatment with intensive chemotherapy. However, after the final course of consolidation chemotherapy, chromosome analysis of his bone marrow aspirates revealed 46XY, t(15,17)(q22;q21), and a PML-RAR alpha fusion gene was detected by the reverse transcriptase- polymerase chain reaction test. All-trans retinoic acid diminished the chromosomal abnormality, but the PML-RAR alpha fusion gene remained. The patient was then treated with CBSCT from an HLA-matched sibling donor. The number of nucleated cells in the cord blood was 2.2 x 10(7)/kg of body weight, and that of granulocyte-macrophage colony-forming units 0.6 x 10(4)/kg. Methotrexate was given, on days 3 and 6, as prophylaxis against graft-versus-host disease (GVHD). The neutrophil count rose to above 500/microliters on day 22. The platelet count exceeded 50,000/microliters on day 48. Platelet transfusions were given 12 times after CBSCT, the last one on day 36. Grade I acute GVHD was treated with steroids. The patient was well and discharged on day 103, without symptoms or laboratory data suggestive of relapse. Following this experience we instituted a project of the Kanagawa Cord Blood Bank, which is scheduled for expansion nationwide. oncolink.com